Clinical Trial Update: Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sunitinib malate in patients with locally recurrent, locally advanced, unresectable, or metastatic urinary tract cancers. The listed co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter
• Urethral Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Hospital del Mar | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: UNKNOWN